Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Sponsor: Massachusetts General Hospital • ClinicalTrials.gov ID: NCT06910969
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The goal of this study is to demonstrate the efficacy of a multidisciplinary group-based telehealth intervention (HORIZONS) compared to minimally enhanced usual care for improving self-management and quality of life for hematopoietic stem cell transplant (HSCT) survivors living with chronic graft-versus host disease, and to identify critical facilitators and barriers for HORIZONS implementation and adoption.
Interventions
-
HORIZONS Intervention
(Behavioral)
Therapist-delivered multidisciplinary group-based telehealth intervention comprised of 8 sessions
-
Minimally enhanced usual care
(Behavioral)
Receiving a standardized booklet with evidence-based information on chronic GHVD management and HST survivorship recommendations
Eligibility criteria
Conditions
Locations
- University of Miami Sylvester Comprehensive Cancer Center — Miami, Florida, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record